Intersect Ent Inc Drug Patent Portfolio

Intersect Ent Inc owns 1 orange book drug protected by 13 US patents Given below is the list of Intersect Ent Inc's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10232152 Systems, devices, and method for treating a sinus condition 24 Nov, 2034
Active
US10406332 Systems, devices, and method for treating a sinus condition 13 Mar, 2034
Active
US8763222 Methods and devices for crimping self-expanding devices 08 Feb, 2032
Active
US10357640 Expandable devices and methods for treating a nasal or sinus condition 03 Oct, 2031
Active
US8025635 Device and methods for treating paranasal sinus conditions 12 Jun, 2027
Active
US7544192 Sinus delivery of sustained release therapeutics 29 Nov, 2026
Active
US9585681 Device and methods for treating paranasal sinus conditions 04 Apr, 2026
Active
US7662141 Sinus delivery of sustained release therapeutics 12 Mar, 2024 Expired
US7713255 Sinus delivery of sustained release therapeutics 12 Mar, 2024 Expired
US7951130 Sinus delivery of sustained release therapeutics 12 Mar, 2024 Expired
US7951131 Sinus delivery of sustained release therapeutics 12 Mar, 2024 Expired
US7951133 Sinus delivery of sustained release therapeutics 12 Mar, 2024 Expired
US8109918 Sinus delivery of sustained release therapeutics 12 Mar, 2024 Expired


Given below is the list of recent legal activities going on the following drug patents of Intersect Ent Inc.

Activity Date Patent Number
Patent litigations
Mail O.P. Petition Decision 12 Apr, 2024 US8109918
Email Notification 12 Apr, 2024 US8109918
Mail-Record Petition Decision of Granted to Make Entity Status large 09 Apr, 2024 US8109918
O.P. Petition Decision 08 Apr, 2024 US8109918
Record Petition Decision of Granted to Make Entity Status large 08 Apr, 2024 US8109918
Petition Entered 13 Feb, 2024 US8109918
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 13 Feb, 2024 US8109918
Payment of Maintenance Fee under 1.28(c) 13 Feb, 2024 US8109918
Email Notification 09 Feb, 2024 US8109918
Change in Power of Attorney (May Include Associate POA) 09 Feb, 2024 US8109918
Payment of Maintenance Fee, 12th Yr, Small Entity 21 Jul, 2023 US8109918
Payment of Maintenance Fee, 4th Year, Large Entity 22 Feb, 2023 US10406332
Payment of Maintenance Fee, 12th Year, Large Entity 22 Feb, 2023 US8025635
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 15 Feb, 2023 US10406332
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 15 Feb, 2023 US8025635


Intersect Ent Inc's Family Patents

Intersect Ent Inc drugs have patent protection in a total of 12 countries. It has a significant patent presence in the US with 51.2% of its patents being US patents. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Intersect Ent Inc Drug List

Given below is the complete list of Intersect Ent Inc's drugs and the patents protecting them.


1. Sinuva

Sinuva is protected by 13 patents, out of which 6 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10232152 Systems, devices, and method for treating a sinus condition 24 Nov, 2034
(10 years from now)
Active
US10406332 Systems, devices, and method for treating a sinus condition 13 Mar, 2034
(9 years from now)
Active
US8763222 Methods and devices for crimping self-expanding devices 08 Feb, 2032
(7 years from now)
Active
US10357640 Expandable devices and methods for treating a nasal or sinus condition 03 Oct, 2031
(6 years from now)
Active
US8025635 Device and methods for treating paranasal sinus conditions 12 Jun, 2027
(2 years from now)
Active
US7544192 Sinus delivery of sustained release therapeutics 29 Nov, 2026
(2 years from now)
Active
US9585681 Device and methods for treating paranasal sinus conditions 04 Apr, 2026
(1 year, 5 months from now)
Active
US7662141 Sinus delivery of sustained release therapeutics 12 Mar, 2024
(6 months ago)
Expired
US7713255 Sinus delivery of sustained release therapeutics 12 Mar, 2024
(6 months ago)
Expired
US7951130 Sinus delivery of sustained release therapeutics 12 Mar, 2024
(6 months ago)
Expired
US7951131 Sinus delivery of sustained release therapeutics 12 Mar, 2024
(6 months ago)
Expired
US7951133 Sinus delivery of sustained release therapeutics 12 Mar, 2024
(6 months ago)
Expired
US8109918 Sinus delivery of sustained release therapeutics 12 Mar, 2024
(6 months ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sinuva's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List